Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,442 INR
Change Today 0.00 / 0.00%
Volume 0.0
TRP On Other Exchanges
Symbol
Exchange
Natl India
OTC US
As of 7:06 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

torrent pharmaceuticals ltd (TRP) Snapshot

Open
1,448
Previous Close
1,436
Day High
1,450
Day Low
1,433
52 Week High
07/28/15 - 1,520
52 Week Low
08/8/14 - 734.00
Market Cap
243.9B
Average Volume 10 Days
332.5K
EPS TTM
44.38
Shares Outstanding
169.2M
EX-Date
06/15/15
P/E TM
32.5x
Dividend
11.25
Dividend Yield
0.78%
Current Stock Chart for TORRENT PHARMACEUTICALS LTD (TRP)

Related News

No related news articles were found.

torrent pharmaceuticals ltd (TRP) Related Businessweek News

No Related Businessweek News Found

torrent pharmaceuticals ltd (TRP) Details

Torrent Pharmaceuticals Limited manufactures and sells branded and unbranded generic pharmaceutical products in India and internationally. The company offers its products in the therapeutic areas of cardiovascular, central nervous system, gastrointestinal, anti-infective, diabetology, pain management, women health, wound care, nutraceuticals, nephrology, and oncology in the form of tablets, capsules, and parenterals. Its active pharmaceutical ingredients comprise nicorandil, risperidone, venlafaxine hydrochloride, ropinarole hydrochloride, duloxetine hydrochloride, ormeloxifen hydrochloride, nebivolol hydrochloride, lamotrigine, sertraline hydrochloride, and clopidogrel bisulphate, as well as atomoxatine hydrochloride, rivastigmine hydrogen tartrate, and esomeprazole sodium. Torrent Pharmaceuticals Limited also provides contract manufacturing services primarily for human insulin. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Private Limited.

11,047 Employees
Last Reported Date: 07/1/15
Founded in 1959

torrent pharmaceuticals ltd (TRP) Top Compensated Officers

Executive Chairman, Managing Director, Member...
Total Annual Compensation: --
Chief Financial Officer and Executive Directo...
Total Annual Compensation: 31.9M
Vice President of Legal, Compliance Officer a...
Total Annual Compensation: 6.8M
Director of Research & Development, Whole-Tim...
Total Annual Compensation: 44.7M
Vice President of Procurement
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

torrent pharmaceuticals ltd (TRP) Key Developments

Torrent Pharmaceuticals Ltd. Reports Audited Standalone and Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2015

Torrent Pharmaceuticals Ltd. reported audited standalone and unaudited consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, on standalone basis, the company reported net sales were INR 18,100 million compared to INR 8,960 million a year ago. Net income from operation was INR 18,670 million compared to INR 9,170 million a year ago. Profit from operations before other income and finance costs was INR 11,200 million compared to INR 3,550 million a year ago. Profit from ordinary activities was INR 11,390 million compared to INR 3,870 million a year ago. Net profit was INR 8,300 million or INR 49.07 per basic and diluted share compared to INR 3,050 million or INR 18.01 per basic and diluted share a year ago. For the quarter, on consolidated basis, the company reported Net Sales were INR 18,860 million compared to INR 10,920 million a year ago. Profit from operations before other income and finance cost was INR 8,500 million compared to INR 3,240 million a year ago. Profit from ordinary activities before tax was INR 8,590 million against INR 3,490 million a year ago. Net profit was INR 4,490 million or INR 26.54 per basic and diluted share compared to INR 2,560 million or INR 15.12 per basic and diluted share a year ago. Revenue was INR 19,470 million compared to INR 11,140 million a year ago. EBITDA was INR 9,740 million compared to INR 3,800 million a year ago.

Torrent Pharmaceuticals Ltd. Appoints Renu Challu as Independent Director

Torrent Pharmaceuticals Ltd. announced that shareholders at the annual general meeting held on July 27, 2015 has appointed Smt. Renu Challu as an independent director on the board of directors of the company to hold the office for a term of three consecutive years effective from July 27, 2015, not liable to retire by rotation.

Torrent Pharmaceuticals Ltd. Approves Interim Dividend and Special Dividend for the Financial Year Ended March 31, 2015

Torrent Pharmaceuticals Ltd. at its AGM held on July 27, 2015, approved the proposal of payment of interim dividend of INR 5.00 per equity share as normal annual dividend and declaration of special dividend of INR 6.25 per equity share as final dividend of fully paid up face value of INR 5.00 each for the financial year ended March 31, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRP:IN 1,441.65 INR 0.00

TRP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Divi's Laboratories Ltd 1,962 INR 0.00
Ipca Laboratories Ltd 676.25 INR 0.00
Jubilant Life Sciences Ltd 263.95 INR 0.00
Piramal Enterprises Ltd 920.20 INR 0.00
Wockhardt Ltd 1,564 INR 0.00
View Industry Companies
 

Industry Analysis

TRP

Industry Average

Valuation TRP Industry Range
Price/Earnings 25.6x
Price/Sales 4.4x
Price/Book 9.7x
Price/Cash Flow 20.6x
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TORRENT PHARMACEUTICALS LTD, please visit www.torrentpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.